Belviq Cancer Lawsuits Move Forward
In February 2020 the Food and Drug Administration (FDA) issued a Drug Safety Communication for the weight-loss drug Belviq. According to the FDA, studies show that Belviq increases the risk of certain types of cancers. In response Easai Inc., the manufacturer of Belviq/Belviq XR, agreed to voluntarily withdraw the drugs…